Click here for slides on this topic


Glimepiride and rosiglitazone

Combination sulfonylurea and thiazolidinedione for glycemic control in type 2 diabetes. Rosiglitazone use restricted in the United States.
The following content matched the glossary term: Glimepiride and rosiglitazone

CompanionSetType2DiabetesMedications

Top

Patient education companion set featuring handouts on DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, and medications used to treat type 2 diabetes (English and Spanish)

Medications Used To Treat Type 2 Diabetes

Top

Patient education handout showing medications used to treat type 2 diabetes and where and how these medications work in the body to lower blood glucose.

Medicamentos para el tratamiento de la diabetes tipo 2

Top

Patient education handout showing medications used to treat type 2 diabetes and where and how these medications work in the body to lower blood glucose—in Spanish.

American Diabetes Association 72nd Scientific Sessions Daily Coverage June 9, 2012

Top

Daily coverage of American Diabetes Association 72nd Scientific Sessions  June 9, 2012

Results from the EASIE, EUREXA, TODAY, and Diabetes Prevention Program (DPP) trials; new data on SGLT2 inhibitors for diabetes treatment, incretins for diabetes treatment, ATP-IV guideline update, and more.

 

ADA/European Association for the Study of Diabetes (EASD) Position Statement on Hyperglycemia Management in Type 2 Diabetes

Top

Joint position statement from ADA/EASD with clinical practice recommendations for managing hyperglycemia in type 2 diabetes

Clinical Insights in Diabetes Newsletter Archive

Top

Clinical Insights® in Diabetes Newsletter Archive

Liraglutide for the Treatment of Type 2 Diabetes: A Clinical Update

Top

Peters KR. Liraglutide for the Treatment of Type 2 Diabetes: A Clinical Update. Am J Ther. 2011 Jun 25. [Epub ahead of print] This review updates the pharmacology, efficacy, safety, and tolerability of liraglutide, a glucagon-like peptide 1 (GLP-1) analog approved for the treatment of type 2 diabetes (T2DM) in January 2010.

The role of pioglitazone in modifying the atherogenic lipoprotein profile

Top

Hanefeld M. The role of pioglitazone in modifying the atherogenic lipoprotein profile. Diabetes, Obesity and Metabolism. 2009;11(8):742-756. Pioglitazone, a thiazolidinedione, has established efficacy in improving glycaemic control in patients with type 2 diabetes. Pioglitazone also improves components of the mixed dyslipidaemia profile common in these patients, as typified by raised levels of plasma triglycerides, low levels of HDL cholesterol (HDL-C) and a raised proportion of LDL cholesterol (LDL-C) occurring as the small dense subfraction.

Product Indications

Top

Medications used to treat diabetes :: Alpha-glucosidase inhibitors, amylin mimetics, biguanides (metformin), bile acid sequestrants, dopamine receptor agonists, DPP-4 inhibitors, GLP-1 analogs, incretins, insulin, meglitinides, SGLT2 inhibitors, sulphonylureas, thiazolidinediones (TZDs).



Slide Library Results

Search Results for: Glimepiride and rosiglitazone Slides Found: 0